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Sonographically Guided Patellar 
Tendon Fenestration
Prognostic Value of Preprocedure Sonographic Findings
atellar tendinosis or jumper’s knee is an overuse injury asso-
ciated with overloading of the knee extensor mechanism
and characterized by pain and tenderness at the inferior pole
of the patella.1,2 The result is mucoid degeneration and possible
micro tears of the involved tendon with absence of inflammatory
cells; therefore, the term “tendinosis” is a more accurate description
of the resultant condition as opposed to “tendinitis.”3 Sonography
has been used to diagnose jumper’s knee where tendinosis appears
as hypoechoic swelling of the tendon with possible increased flow
on color and power Doppler imaging; coexisting interstitial tears
appear as anechoic clefts.3
Yassine Kanaan, MD, Jon A. Jacobson, MD, David Jamadar, MBBS, Jeffrey Housner, MD,
Elaine M. Caoili, MD
Received August 29, 2012, from the Department
of Radiology, Texas Scottish Rite Hospital for
Children, Dallas, Texas USA (Y.K.); and
Departments of Radiology (J.A.J., D.J., E.M.C.)
and Orthopedic Surgery (J.H.), University of
Michigan, Ann Arbor, Michigan USA. Revision
requested September 18, 2012. Revised manu-
script accepted for publication October 10, 2012.
Address correspondence to Jon A. Jacobson,
MD, Department of Radiology, University of
Michigan, 1500 E Medical Center Dr, TC2910L,
Ann Arbor, MI 48109-5326 USA.
E-mail: jjacobsn@umich.edu
P
©2013 by the American Institute of Ultrasound in Medicine | J Ultrasound Med 2013; 32:771–777 | 0278-4297 | www.aium.org
ORIGINAL RESEARCH
Objectives—The purpose of this study was to determine whether any sonographic features
of jumper’s knee can predict the outcome after sonographically guided percutaneous
patellar tendon fenestration.
Methods—Patients were identified between July 2001 and March 2009 who had clin-
ical and sonographic findings of jumper’s knee, who had failed conservative treatment,
and who had sonographically guided percutaneous fenestration of the patellar tendon.
Pain levels were assessed before and 4 weeks after fenestration. Sonograms were retro-
spectively characterized with regard to echogenicity, size, definition, location, calcifica-
tion, and hyperemia of the abnormal patellar tendon region. Sonographic findings
before fenestration were correlated with clinical outcomes.
Results—A total of 45 patellar tendons (32 consecutive patients) were included in
the study. The average prefenestration functional pain score was 3.6 (range, 2–5),
and the average postprocedure functional pain score after 4 weeks was 1.4 (range, 0–5).
The preprocedure sonographic finding that correlated with an improved clinical out-
come after tendon fenestration was the presence of a well-defined tendon abnormality.
No other sonographic findings were associated with the clinical outcome. After fenes-
tration, 76% (34 of 45) showed clinical improvement; 24% (11 of 45) showed no
change; and 0% (0 of 45) had worse symptoms at 4 weeks.
Conclusions—The presence of a well-defined area of tendinosis on sonography was
associated with clinical improvement after percutaneous sonographically guided fen-
estration of the patellar tendon. All tendons either improved (76%) or showed no
change (24%) in the functional pain score at 4 weeks after fenestration. 
Key Words—fenestration; patellar tendon; sonography; tenotomy
3205jumonline.qxp:Layout 1  4/22/13  8:51 AM  Page 771
In addition to sonography’s role in the diagnosis of
tendon abnormalities, it has also been used to guide percu-
taneous tendon treatments. Tendon fenestration (dry
needling or tenotomy) has been evaluated as a treatment
option for chronic tendinosis of the Achilles tendon, com-
mon extensor tendon origin at the elbow, and others,
including the patellar tendon.4 After percutaneous sono-
graphically guided fenestration of the patellar tendon,
excellent or good satisfaction scores have been reported in
81% of patients.5 However, identification of sonographic
findings that would predict a positive outcome after sono-
graphically guided fenestration would be helpful in the selec-
tion of patients who may be considered for this treatment.
In our clinical practice, we have noted variable appear-
ances of patellar tendinosis on sonography with regard to
echogenicity, size of the tendon abnormality, and vascu-
larity on color and power Doppler imaging. It is unclear
whether increased vascularity is beneficial when performing
fenestration, as hemorrhage and growth factor release are
proposed mechanisms for tendon healing. The purpose of
this study was to determine whether sonographic features
of jumper’s knee predict the clinical outcome of sono-
graphically guided patellar tendon fenestration. 
Materials and Methods
Patients
Institutional Review Board approval was obtained, and
informed consent was waived. Patients who had sono-
graphically guided patellar tendon fenestration at the dis-
cretion of the sports medicine physician were identified
from the radiology information system between July 2001
and March 2009. All patients had sonographically guided
tendon fenestration as part of their routine clinical care if
the following criteria were met: (1) history and physical
examination findings were consistent with patellar tendi-
nosis as determined by a fellowship-trained sports medicine
physician; (2) sonographic findings showed tendinosis; and
(3) the patient failed to respond to conservative treatment,
including relative rest, pain medication, and physical therapy.
Exclusion criteria were patients younger than 18 years,
duration of symptoms less than 6 months, those who had
prior patellar tendon surgery or fenestration, and patients
with normal sonographic results. Of note, the patients in
this study were part of a prior study that assessed patient
outcomes after percutaneous sonographically guided
fenestration.5 In contrast to that prior study, this research
compared sonographic findings to a change in the func-
tional pain score after fenestration. 
Clinical Examination
All participants underwent a clinical knee examination as
part of routine patient care by a fellowship-trained sports
medicine physician with 13 years of experience. Additional
imaging, such as magnetic resonance imaging and radiog-
raphy, was also performed at the discretion of the sports
medicine physician. Each patient was also assessed for the
level of functional pain before tendon fenestration using
the following classification: 0, no pain; 1, pain only after
intense sports activity, no undue functional impairment;
2, pain at the beginning and after sports activity, still able to
perform at a satisfactory level; 3, pain during sports activ-
ity, increasing difficulty in performing at a satisfactory level;
4, pain during sports activity, unable to participate in sports
at a satisfactory level; and 5, pain during daily activity,
unable to participate in sports at any level.6
Sonographic Examination
Sonography was performed by one of two fellowship-
trained musculoskeletal radiologists (each with >12 years
of experience) using high-resolution sonography includ-
ing color or power Doppler with 7–15-MHz linear trans-
ducers (HDI 5000 and iU22; Philips Healthcare, Bothell,
WA). Liberal transmission gel was used in place of a stand-
off pad, and the patellar tendon was evaluated in both long
and short axes. 
Fenestration Procedure
For the percutaneous tendon fenestration procedure,
needling was performed by the fellowship-trained sports
medicine physician in conjunction with the fellowship-
trained musculoskeletal radiologist who provided sono-
graphic guidance. A sterile field was set up and maintained
throughout the procedure. A 27-gauge needle (Becton
Dickinson and Company, Franklin Lakes, NJ) was first
used to anesthetize the skin with a 1:1 mixture of 1% lido-
caine to 0.25% bupivacaine. The syringe was then switched
over to a 22-gauge needle (Becton Dickinson and Company)
to perform the fenestration of the focal abnormalities
within the tendon. The needle was guided from an infe-
rior-to-superior approach, long axis to the patellar tendon,
and in plane with the transducer and ultrasound beam.
Approximately 20 to 30 needle passes were made through
the abnormal region of the tendon with real-time sono-
graphic imaging for continual guidance. Typically, initial
passes through the focal abnormalities were resistant to
needling, producing palpable crepitation, which eventu-
ally would resolve as the focal tendon abnormality soft-
ened. If the tendon abnormality included the bone-tendon
interface, this area was specifically targeted as well. The
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procedure was determined to be complete when the needle
had been passed through all abnormal regions of the ten-
don and enthesis at least once. In each case, the needle was
advanced along the long axis of the transducer only when it
was visualized sonographically to ensure accurate needle
placement. Up to 3 mL of the lidocaine-bupivacaine mix-
ture was injected into the tendon to maintain anesthesia as
needed. If calcifications were identified on sonography, these
areas were targeted with the same 22-gauge needle to disrupt
and mechanically fragment the calcifications. 
Postfenestration Clinical Examination and Follow-up
The postprocedure protocol consisted of relative rest until
the first follow-up appointment at 4 weeks. Patients were
allowed to continue usual activities of daily living during
that period, with the addition of strengthening exercises
beginning at 2 weeks after the procedure. All patients were
evaluated at 4 weeks by the same fellowship-trained sports
medicine physician, who recorded their functional pain
measurement using the same classification scale as the pre-
procedure assessment. 
Retrospective Sonogram Interpretation
Two musculoskeletal radiologists (each with >12 years of
experience with musculoskeletal sonography) reviewed
the sonograms retrospectively in consensus to characterize
the patellar tendon abnormalities. The following data were
recorded: length (centimeters), width (centimeters),
anteroposterior dimension (centimeters), definition (well
defined or poorly defined) of the focal tendinosis (hypo -
 echoic abnormality), presence or absence of an interstitial
tendon tear (anechoic clefts), ratio of the abnormal tendon
echogenicity to the entire thickness of the tendon meas-
ured in the anteroposterior dimension, distance of the focal
tendinosis from the patella, patellar cortical irregularity,
and presence of calcification within the patellar tendon
(echogenic foci with possible shadowing). The presence
and location of increased vascularity on color or power
Doppler imaging (if performed) were also evaluated, and
the degree of increased vascularity was graded as high
(>50% of the abnormal tendon area) or intermediate
(<50% of the abnormal tendon area). Both radiologists
were blinded to the clinical outcome and all patient infor-
mation. Patient medical records were also reviewed.
Analysis
A 1-way analysis of variance model was used to evaluate
the continuous variables to determine whether there were
any significant differences among the functional pain scores.
The Fisher exact test was used to determine whether the
presence of specific imaging features was associated with
preprocedure and postprocedure functional pain scores.
For all analyses, P < .05 was considered to indicate statis-
tical significance.
Results
A total of 45 patellar tendons (32 consecutive patients) were
included in the study. There were 6 female and 26 male
patients with an age range of 19 to 51 years (average, 26
years). The average prefenestration functional pain score
was 3.6 (range, 2–5), comprising 0% (0 of 45) of patellar
tendons with a score of 0 or 1, 4% (2 of 45) with a score of
2, 42% (19 of 45) with a score of 3, 47% (21 of 45) with a
score of 4, and 7% (3 of 45) with a score of 5. There were
no immediate complications after the tendon fenestration
procedure or at 4 weeks after the procedure.
With regard to the preprocedure sonographic findings
(Figures 1 and 2), tendinosis measured an average of
13.2 mm (range, 1.3–25 mm) in the craniocaudal dimen-
sion and an average of 9.6 mm (range, 1.5–18 mm) in the
transverse dimension (mediolateral). The average tendon
abnormality in the anteroposterior dimension was 2.7 mm
(range, 2.1–9.3 mm). The ratio of the tendon abnormality
in the anteroposterior dimension to the overall antero-
posterior tendon thickness was 72% (range, 39%–88%).
The tendon abnormality was well defined in 80% (36 of 45;
Figure 1) and poorly defined in 20% (9 of 45). Interstitial
tears were present in 18% (8 of 45; Figure 2). The average
distance of tendinosis from the patella was 0.6 mm (range,
0–10 mm) with cortical irregularity of the patella present
in 78% (35 of 45). Calcification was present within the area
of tendinosis in 31% (14 of 45). Color or power Doppler
imaging was used in 29 cases, which showed increased
vascularity within the abnormal tendon in 52% (15 of 29)
of the cases (Figure 1): high vascularity in 2 cases and inter-
mediate in 13 cases. Of these 29 tendons, 34% (10 of 29)
showed increased vascularity around the tendinosis (9 inter-
mediate and 1 high vascularity).
The average 4-week postfenestration functional pain
score was 1.4 (range, 0–5), comprising 31% (14 of 45)
patellar tendons with a score of 0 (Figure 1), 36% (16 of 45)
with a score of 1, 4% (2 of 45) with a score of 2, 16% (7 of 45)
with a score of 3, 9% (4 of 45) with a score of 4, and 4%
(2 of 45) with a score of 5. After fenestration, 76% (34 of
45) showed an improved functional pain score (Figure 3).
The average postfenestration functional pain score of 1.4
decreased from the average preprocedure score of 3.6. For
the interval change in each individual functional pain score
(Figure 3), 24% (11 of 45) of the patellar tendons had no
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change; 7% (3 of 45) had a change of 1 scores; 27% (12 of
45) had a change of 2 scores; 22% (10 of 45) had a change
of 3 scores; 20% (9 of 45) had a change of 4 scores; and
0% (0 of 45) had a change of 5 scores. Of note, any change
in the functional pain score was associated with an improve-
ment rather than a detriment. One sonographic finding,
the presence of a well-defined hypoechoic tendon abnor-
mality, showed a statistically significant association with an
improved clinical outcome, as indicated by an interval
decrease in the functional pain score (P = .02). Of the 36
patellar tendons that showed well-defined tendinosis, 81%
(29 of 36) showed improvement in the pain score after
sonographically guided fenestration. All other sonographic
findings did not significantly correlate with an improved
clinical outcome at 4 weeks after fenestration (interstitial tear,
P = .68; cortical irregularity, P = .51; calcification, P = .25;
and vascularity, P = .84).
Discussion
Sonographically guided tendon fenestration has been
investigated as a treatment option for jumper’s knee.4,5
Our results show that patients with well-defined tendinosis
of the patellar tendon on sonography showed significant
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Figure 1. Images from a 21-year-old woman with jumper’s knee who had improvement of her functional pain score from 4 to 0 after fenestration.
Long-axis (A) and short-axis (B) sonograms of the proximal patellar tendon show well-defined hypoechoic tendinosis (arrows). Arrowheads indi-
cate patellar tendon; and P, patella. Color Doppler sonogram (C) shows increased flow. Long-axis sonogram (D) shows the needle (curved arrows)
during tenotomy.
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clinical improvement 4 weeks after sonographically guided
tendon fenestration. All other sonographic findings, includ-
ing hyperemia, were not significantly associated with the
outcome after fenestration. After fenestration, 76% (34 of
45) of patellar tendons showed clinical improvement;
24% (11 of 45) showed no change; and in no cases did
symptoms become worse.
Patellar tendinosis or jumper’s knee is clinically char-
acterized by activity-related pain and soreness of the patel-
lar tendon at the inferior pole of the patella. This condition
is likely associated with overloading of the knee extensor
mechanism and is a common overuse injury in professional
athletes, especially those engaged in explosive jumping
sports.6 In athletic populations, the estimated incidence of
jumper’s knee is between 13% and 20%.7,8 Patellar tendi-
nosis may be difficult to treat and can be a source of chronic
symptoms.9
The injection therapies that have been used to treat
patellar tendinosis have a similar fundamental principal of
intentionally changing a chronic injury into an acutely injured
state in the hope of inducing a high potential for healing.10
The mechanism of the healing process is not well under-
stood; therefore, many theories are proposed. One hypoth-
esis suggests that disruption of the fibers within the focal
tendinosis causes hemorrhage and a subsequent inflamma-
tory response, which incites the formation of granulation tis-
sue that strengthens the tendon.11 Some investigators have
found that preparations rich in growth factors, such as a
platelet-rich clot, induce cell proliferation and synthesis of
angiogenic factors in vitro.12 Others have theorized that
basic fibroblast growth factor and transforming growth
factorβmay act as humoral mediators in the stimulation of
the healing process.13
Although there are data that support the benefit of
tendon fenestration or dry needling alone in the treatment
of tendinosis, there are other injection therapies and sur-
gical options available. One such injection therapy involves
the injection of a sclerosing agent, polidocanol, which is
used to target and obliterate neovascularity.14–16 Injections
of growth factors via autologous whole blood or platelet-
rich plasma have also been suggested as minimally invasive
therapies that promote healing.10,17–22 Prolotherapy involves
injection of an irritant (eg, hyperosmolar dextrose) that
causes a local inflammatory response and up-regulation of
growth factor expression, which results in collagen syn-
thesis and a stronger tendon.23 Most of these injection
therapies and dry-needling procedures described in the
literature have been performed with the use of sonographic
guidance because sonography can localize the tendon
abnormality and accurately guide needle placement.
J Ultrasound Med 2013; 32:771–777 775
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Figure 2. Images from a 51-year-old man with jumper’s knee who had
improvement of his functional pain score from 3 to 1 after fenestration.
Long-axis (A) and short-axis (B) sonograms of the proximal patellar ten-
don show a well-defined anechoic region interpreted as an interstitial
tear (arrows) with surrounding hypoechoic tendinosis. Arrowheads indi-
cate patellar tendon; and P, patella. 
A
B
Figure 3. Change in functional pain scores. A higher score indicates
more severe symptoms.
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The surgical options for treatment of jumper’s knee include
excision of tendinotic tissue and curettage or drilling of the
inferior patellar pole. Some less common procedures
involve excision of the inferior patella and percutaneous
longitudinal incisions of the patellar tendon.24,25
The sonographic features of jumper’s knee are well-
established.3 Tendinosis appears as abnormal hypo -
 echogenicity of the tendon with variable flow on color or
power Doppler imaging, whereas interstitial tears appear
as anechoic clefts.3 Involvement of the posterior aspect of
the proximal patellar tendon is common; hyperechoic and
shadowing calcifications and adjacent patellar cortical
irregularity may be seen. With regard to the sonographic
findings of jumper’s knee in our study, patients with a well-
defined margin of the patellar tendon abnormality had a
statistically significant correlation with a positive clinical
response to sonographically guided tendon fenestration at
4 weeks, indicated by an improved functional pain score.
The other sonographic variables related to grayscale and
color or power Doppler imaging did not show a statistical
correlation with a clinical outcome.
With regard to increased blood flow in the setting of
tendinosis, several investigations have shown that
increased vascularity represents neovascularity, which
correlates with symptoms when evaluating the Achilles
and patellar tendons.15,26–28 In addition, sonographically
guided sclerosis of the patellar tendon neovascularity at
the ventral surface of the patellar tendon with polidocanol
has shown to improve patient symptoms with moderate
improvement in knee function.29 One of our hypotheses
was that abnormal patellar tendons with more neovascu-
larity would be associated with clinical improvement after
tendon fenestration, as the neovascularity would be an
ideal source for hemorrhage and intrinsic growth factors;
however, that was not the case in our study. Of note, it
has been shown that the presence of neovascularity of the
Achilles tendon does not predict the clinical outcome
after conservative treatment, unlike the presence of ten-
don inhomogeneity, which was associated with a poor
outcome.28
With regard to the other sonographic variables that
were assessed, we also hypothesized that a larger area of
tendinosis or an area with interstitial tears would show
less clinical improvement; however, that was not the case.
One explanation for the lack of significance between most
of the sonographic findings of jumper’s knee and the clin-
ical outcome is the fact that 76% of patients improved 4
weeks after the procedure, and no patients had worsening
of symptoms. Further studies are needed with a larger sam-
ple size to address this possible explanation.
We acknowledge several limitations of this study.
A selection bias may have been introduced because only
patients who failed conservative treatment were included.
Retrospective review of the sonograms may have also intro-
duced error; however, videos or cine clips were recorded
during each examination and were used as part of the ret-
rospective review process, which was completed by two
radiologists blinded to clinical data. In addition, long-
term clinical follow-up assessment comparing prefenes-
tration and postfenestration findings was not completed.
Last, there was the lack of a control group or comparison
treatment group, such as autologous blood or platelet-
rich plasma injection.
In conclusion, the presence of a well-defined area of
tendinosis of the patellar tendon correlated significantly
with clinical improvement of patients with jumper’s knee
4 weeks after sonographically guided patellar tendon
fenestration. Other sonographic findings, such as increased
vascularity, did not correlate with clinical improvement.
All patients treated with sonographically guided percuta-
neous patellar tendon fenestration either improved (76%)
or showed no change (24%) in their functional pain scores. 
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